-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA Grants Orphan Drug Designation To Novartis’ Rapcabtagene Autoleucel For Treatment Of Idiopathic Inflammatory Myopathies

Benzinga·10/19/2026 15:15:04
Diffusion vocale

http://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1147426